Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease

OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...

Full description

Saved in:
Bibliographic Details
Published in:Ann Clin Transl Neurol
Main Authors: Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2015
Subjects:
Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/
https://ncbi.nlm.nih.gov/pubmed/26783546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items